SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Beasley Broadcast Group, Inc. is multi-platform media company, which engages in the operation of radio stations in the United States. The firm offers marketing solutions across event platforms. It operates through the following business segments: Audio, Digital, and Other. The company was founded by George G. Beasley in 1961 and is headquartered in Naples, FL.

Beasley Broadcast Group Inc - Ordinary Shares - Class A

BBGI is trending due to high volatility and a potential short squeeze, fueled by its low float and lack of active shelf offerings. The community is actively discussing price targets and the possibility of a significant run, drawing comparisons to other stocks with similar setups. The stock has experienced multiple trading halts, contributing to the intense interest and speculation.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Shares of Netflix are under pressure, as the community debates the potential outcomes of the Warner Bros. Discovery bidding war. Some believe Netflix is overpaying or taking on too much debt with the deal, while others speculate about potential regulatory hurdles, a breakup fee, or the company's prospects if the deal falls through. Overall, the stock's recent performance has spurred a lot of discussion about its current valuation and future direction.

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company was founded on February 10, 2012 and is headquartered in Midland, PA.

Mawson Infrastructure Group Inc

MIGI is trending due to its low float, high volatility, and unique position as a hybrid infrastructure play in the crypto mining sector. Community members are anticipating updates from the company's upcoming conference, which could act as a major catalyst. Traders are drawn to MIGI's explosive potential, as even small buys can significantly move the price.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending as the market anticipates the Fed's rate decision and Powell's press conference, with community members debating the potential impact on the market's direction. Discussions revolve around whether the Fed will cut rates, the possibility of QE, and the implications of a hawkish or dovish stance. Some traders are also noting news of the U.S. seizing an oil tanker off Venezuela, adding another layer of uncertainty.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as community members discuss its failure to keep pace with broader market gains and its underperformance relative to other tech giants. Some speculate on potential shifts in AI partnerships and the impact of competition from Google, while others point to institutional accumulation and long-term growth potential. The stock's struggle to surpass key resistance levels is also a focal point of discussion.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as the market anticipates potential rate cuts, especially after recent dovish signals from Fed officials. Community discussions revolve around whether current valuations justify further upside, with some expressing concerns about a potential AI bubble. Bond market participants are closely watching economic data releases for further cues on the Fed's policy path.

Enveric Biosciences, Inc. is a biotechnology company which engages in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company was founded on February 28, 1994 and is headquartered in Cambridge, MA.

Enveric Biosciences Inc

Enveric Biosciences is trending due to a recent patent allowance for its EVM301 series, sparking discussion of a potential short squeeze given the stock's low float. The community is weighing the significance of the new IP against the company's history of dilution, while also speculating about a possible settlement with AbbVie. Some traders express optimism for a continued run, while others remain cautious.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending amid expectations surrounding the Fed's rate decision and commentary on future monetary policy, with potential implications for AI spending. Community members are actively discussing possible market reactions and impacts of a rate cut, and some express concerns about the Fed's influence. Traders are closely watching key levels and anticipating volatility, while also debating the influence of AI on the economy.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending as discussions revolve around the potential impact of SpaceX's increased valuation and possible IPO on the space sector, with community members drawing valuation comparisons. Anticipation is building for the company's upcoming launch, while some traders discuss technical indicators and potential short squeezes.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting Carriers with Shippers on its platform, and gives Carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is trending downwards, with community discussion focusing on potential competition from Waymo and the stock's recent performance despite positive fundamentals. Some investors are speculating about a buying opportunity, while others express concern about the stock's price action and potential manipulation. The recent partnership announcements and broader trends in the autonomous vehicle space are also being closely watched.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pharvaris (NASDAQ:PHVS) Given New $30.00 Price Target at Bank of America

Bank of America increased their price objective on shares of Pharvaris from $27.00 to $30.00 and gave the company a "neutral" rating in a research note on Thursday...

Pharvaris (NASDAQ:PHVS) Given "Buy" Rating at HC Wainwright

HC Wainwright reiterated a "buy" rating and issued a $60.00 price target on shares of Pharvaris in a research report on Wednesday...

Pharvaris Stock Gains on HAE Drug Meeting Late-Stage Study Goals

PHVS shares jump as deucrictibant delivers rapid symptom relief in RAPIDe-3, boosting momentum toward a planned 2026 regulatory filing.

Pharvaris (NASDAQ:PHVS) Sees Large Volume Increase - Should You Buy?

Pharvaris (NASDAQ:PHVS) Sees Strong Trading Volume - Here's What Happened...

<ul class="summary-bullets"><li>Pharvaris shares jumped in early Wednesday trading after the company reported positive Phase 3 data for its oral HAE drug deucrictibant.</li><li>Results will be used to support regulatory approval filings expected in early 2026.</li><li>The drug is positioned as an oral alternative to current injectable HAE therapies, which many patients find difficult to use.</li></ul>Shares of Pharvaris (PHVS) rose in early morning trade on Wednesday after the company reported positive Phase 3 results for its oral drug deucrictibant, aimed at treating hereditary angioedema (HAE).HAE is a rare condition that causes sudden, severe swelling attacks. The RAPIDe-3 Phase 3 study is Pharvaris’ first trial for on-demand treatment of HAE attacks. The data will support marketing approval filings in early 2026.<a href="https://stocktwits.com/symbol/PHVS/sentiment">PHVS’ stock</a> rose as much as 20% in pre-market trade and was among the top trending tickers on Stocktwits. Retail sentiment around the company on the platform trended in ‘extremely bullish’ territory, accompanied by chatter at ‘extremely high’ volumes.<h2 class="st-heading-2">RAPIDe-3 Study Results</h2>The global RAPIDe-3 trial tested deucrictibant against a placebo in 134 patients across 24 countries, including adolescents and adults with different forms of HAE. The drug, taken as a 20 mg capsule, was designed for on-demand use during attacks.The results showed that the drug worked quickly and effectively. The company said patients reported initial symptom relief in just about 1.3 hours, compared with more than 12 hours for placebo. Full symptom resolution occurred in under 12 hours, compared with over a day in the placebo group. Most attacks were managed with a single capsule, and 93% of patients didn’t need extra medication.Currently, most effective HAE treatments are injections, which many patients find inconvenient. Pharvaris is working on pills that block a pathway called the bradykinin B2 receptor — the same pathway targeted by injectable drugs — to offer an easier alternative.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-climbs-above-93-000-wiping-out-over-400-million-in-shorts-bets/cLIXFLUREKy">Bitcoin Climbs Above $93,000, Wiping Out Over $400 Million In Short Bets</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stocks, shares background - stock photo (representative image courtesy of Sean Gladwell via Getty Images)

PHVS Stock Jumps After Phase 3 Trial Shows Rapid Symptom Relief For Oral HAE Treatment 

The RAPIDe-3 Phase 3 study is Pharvaris’ first trial for on-demand treatment of HAE attacks.

Equity

Pharvaris (NASDAQ:PHVS) Sets New 1-Year High - What's Next?

Pharvaris (NASDAQ:PHVS) Sets New 52-Week High - Here's Why...

Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Johannes Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.

PHVS
Pharvaris NV

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PHVS News

PHVSPharvaris NV